The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan

INTRODUCTION: Upadacitinib is a Janus kinase inhibitor with demonstrated efficacy in patients with rheumatoid arthritis (RA). OBJECTIVE: The aim of this study was to assess the long-term safety of upadacitinib in patients with active RA from Japan compared with global clinical trial populations. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaoka, Kunihiro, Tanaka, Yoshiya, Kameda, Hideto, Khan, Nasser, Sasaki, Nobuhito, Harigai, Masayoshi, Song, Yanna, Zhang, Ying, Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184701/
https://www.ncbi.nlm.nih.gov/pubmed/34041702
http://dx.doi.org/10.1007/s40264-021-01067-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184701/
https://www.ncbi.nlm.nih.gov/pubmed/34041702
http://dx.doi.org/10.1007/s40264-021-01067-x

Ejemplares similares